Accounts Receivable, after Allowance for Credit Loss, Current in USD of INNOVATIVE MEDTECH, INC. from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Innovative Medtech, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q2 2020 to Q3 2024.
- Innovative Medtech, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2024 was $166K, a 26% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)